AMRI has been recognised for its excellence as a CMO and has been honoured as part of the Life Science Leader’s 2017 CMO Leadership Awards in five categories — capabilities, compatibility, expertise, quality and reliability.
The global contract research, development and manufacturing organisation has been working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years.
Presented annually by Life Sciences Leader, the CMO Leadership Awards ensure that quality ratings come from companies that have worked with the CMO within the last 18 months and that results are backed by experiential data. CMOs were eligible to win recognition from up to three groups of respondents: big pharma, small pharma and overall. AMRI earned recognition in all three groups.
“Each year, the CMO Leadership Awards recognise the success that individual drug development and manufacturing organisations have in serving the needs of their biotechnology and pharmaceutical customers and partners,” said Louis Garguilo, executive editor of Life Sciences Leader magazine and OutsourcedPharma.com.
“Competing with more than 80 contract manufacturers, AMRI is honoured to be recognised by our customers from industry pharma and biopharma companies,” added William S. Marth, president and CEO of AMRI. “We have made several acquisitions that have increased our strength and scale, invested in our core legacy businesses and have grown to more than 3000 employees globally. This growth, coupled with expanded services — including extractables and leachables, sterile APIs and pre-filled syringes — solidly positions us to continue to deliver development and manufacturing services, regardless of size and complexity.”